While Pliant Therapeutics and Acelyrin recently blocked ever-eager acquirer Concentra Biosciences with “poison pill” defenses, struggling Allakos is welcoming a $0.33 per share buyout offer wi ...

Concentra Group Holdings Parent, Inc. (“Concentra,” “the Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of ...

US-based occupational health services provider Concentra Group Holdings Parent has entered a definitive agreement for the acquisition of Pivot Onsite Innovations from Athletico Physical Therapy ...